Quantcast

Latest Diabetes management Stories

2014-02-26 23:02:16

DailyGossip.org publishes a review that aims to help patients suffering from diabetes. The magazine indicates that Reverse Your Diabetes Today is one of the most effective programs that sufferers may use with the purpose to improve their condition. Denver, Colorado (PRWEB) February 26, 2014 According to the review published by http://www.DailyGossip.org, the Reverse Your Diabetes Today program promises to be so effective that it will help sufferers improve their disease in no more than 3...

2014-02-25 23:04:57

GIA announces the release of a comprehensive global report on Hemoglobin A1c Monitoring markets. Global market for Hemoglobin A1c Monitoring is projected to exceed US$2 billion by 2020 driven by the continuous rise in diabetic population worldwide, and the pressing need for diabetes management through continuous monitoring. San Jose, California (PRWEB) February 25, 2014 Follow us on LinkedIn - Hemoglobin A1c (HbA1c) monitoring is one of the rapidly growing markets in the diagnostics...

2014-02-25 14:31:32

Addressing participants' moods and their treatment management skills may bring faster relief of depression symptoms Although maintaining good blood sugar control is crucial for avoiding complications of diabetes, it has been estimated that only about half of patients are successful in meeting target blood glucose levels. The prevalence of depression among diabetes patients – up to twice as high as in the general population – can interfere with patients' ability to manage their...

2014-02-25 08:31:50

Once-Weekly Dulaglutide Hits Primary Endpoint in Sixth Consecutive AWARD Trial INDIANAPOLIS, Feb. 25, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive top-line results of the sixth AWARD (Assessment of Weekly AdministRation of LY2189265 in Diabetes) trial for once-weekly dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a treatment for type 2 diabetes. In the AWARD-6 study, once-weekly...

2014-02-21 08:25:23

Trial Seeks to Examine the Effects of INVOKANA® on the Progression of Diabetic Nephropathy RARITAN, N.J., Feb. 21, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced the initiation of CREDENCE (Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation), a global, multicenter study of INVOKANA(®) (canagliflozin). This Phase 3 study is a randomized, double-blind, placebo-controlled, parallel group trial designed to enroll...

2014-02-20 08:29:50

Proceeds to be used to continue the launch of the DarioTM Diabetes Management Solution CAESAREA, Israel, Feb. 20, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has successfully closed its previously announced $4.19 million common stock and warrant private placement financing that priced on February 13, 2014. LabStyle intends to use the aggregate net proceeds of the financing,...

2014-02-18 08:32:39

To widen market potential, pharma companies must roll out long-lasting therapies that delay or prevent disease progression BUENOS AIRES, Argentina, Feb. 18, 2014 /PRNewswire/ -- The Latin American diabetes therapeutics market will experience major changes within the next three years due to the launch of innovative drugs that include three long-acting insulins and four non-insulin treatments. Nevertheless, pharmaceutical companies should continue their research to develop treatments that can...

2014-02-12 12:31:50

In an unprecedented, challenging environment for reimbursement and choice for people with diabetes, ACCU-CHEK remains highest ranked brand INDIANAPOLIS, Feb. 12, 2014 /PRNewswire/ -- J.D. Power has announced that Roche Diabetes Care's ACCU-CHEK products rank "Highest in Customer Satisfaction with Blood Glucose Meters" among adults living with diabetes in the U.S. for the second year in a row according to the 2013 Blood Glucose Meter Satisfaction Study(SM). In a study comprised of...

2014-02-12 08:28:24

Clinical program focused on reversing type 1 diabetes symptoms in patients diagnosed within six months of trial initiation EDGEWATER, N.J. and SAN DIEGO, Feb. 12, 2014 /PRNewswire/ -- DiaVacs, Inc., a clinical stage biotechnology company focused on developing cell-based therapy for treatment of type 1 diabetes, and Profil(® )Institute for Clinical Research, Inc., an early phase clinical research organization focused on diabetes and obesity, announced today a strategic collaboration...

2014-02-11 23:28:04

Achieve is conducting a placebo-controlled, multicenter study to evaluate the blood pressure reduction with ambulatory blood pressure monitoring (ABPM), safety, and tolerability of a new drug in the treatment of subjects with hypertension and type 2 diabetes mellitus. Birmingham, AL (PRWEB) February 11, 2014 Achieve is conducting a placebo-controlled, multicenter study to evaluate the blood pressure reduction with ambulatory blood pressure monitoring (ABPM), safety, and tolerability of a...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.